Biotech's comeback continues Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 22 July, 2026

J.P. Morgan was the right banking team for Montara Therapeutics. Founder Nicholas Hertz trusted the team’s life sciences expertise, security, and support to focus on what mattered most. sponsored by J.P.Morgan

presented by HIV Ends Here: In­side Vi­iV Health­care’s Sin­gu­lar Mis­sion

news Summit reports two-year survival data for Western patients, though context lacking Bioregnum The biotech recovery gathers speed in Q2 Vertex was only bidder for Crinetics in year's second-highest M&A premium Celldex scraps antibody in itchy skin nodules after Phase 2 flop Trump pledges new tariffs on generic drugs not made in the US

Jul 30 1:00 pm ET Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights sponsored by GUARDANT Aug 19 1:00 pm ET From pilots to production: AI across R&D, safety, regulatory, and clinical sponsored by IBM

Associate Director / Director, Preclinial Development - Immunology Terray Therapeutics, Inc. Monrovia, CA, USA Senior Director, Licensing Officer Bayer Cambridge, MA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

The most differentiated science stays out of public view. This September, the Endpoints newsroom reveals the 11 private companies worth watching, live at the State Room in Boston. See the list first, reserve your spot and save with the early bird rate.

ENDPOINTS PHARMA Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses FDA plans to name permanent CBER, CDER heads with new commissioner nomination Indian generic drugmaker gets FDA warning over clinical study consent

in case you missed it 1. For Novartis' CEO, China deals aren't a strategy shift — just where the science is 2. Broad Institute launches Center for Therapeutic Genetics for rare diseases 3. Agios’ second shot at sickle cell disease falls short 4. Exclusive: A David Baker spinout launches AI antibody data consortium with GSK, Boltz and others 5. News Briefing Gilead and Merck provide HIV data; Dimension Capital announces $800M fund